Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
121 studies found for:    bay pines
Show Display Options
Rank Status Study
21 Completed
Has Results
Study of Thymosin Beta 4 in Patients With Pressure Ulcers
Condition: Pressure Ulcers
Interventions: Drug: Placebo;   Drug: Thymosin Beta 4
22 Completed SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism
Condition: Pulmonary Embolism
Interventions: Drug: SR34006;   Drug: (LMW)heparin;   Drug: Warfarin VKA;   Drug: Acenocoumarol VKA
23 Active, not recruiting CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial
Conditions: Carcinoma, Basal Cell;   Carcinoma, Squamous Cell;   Skin Neoplasms;   Skin Diseases;   Neoplasms, Basal Cell;   Neoplasms, Squamous Cell;   Carcinoma
Interventions: Drug: 5-fluorouracil;   Drug: Placebo, vehicle control
24 Completed To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia
Conditions: Schizoaffective Disorder;   Schizophrenia
Interventions: Drug: Haloperidol;   Drug: Olanzapine
25 Completed Randomized, Controlled Multicenter Trial of Vacuum Assisted Closure Therapy™ in Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcers
Intervention: Device: Moist Wound Therapy
26 Completed
Has Results
Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
Conditions: Deep Vein Thrombosis;   Pulmonary Embolism
Interventions: Drug: Enoxaparin + Placebo;   Drug: Apixaban + Placebo
27 Completed Dose Finding Study in COPD
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: BEA 2180 BR;   Drug: tiotropium
28 Completed
Has Results
A Safety and Efficacy Study of INTEGRA® Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers
Condition: Neuropathic Diabetic Ulcer - Foot
Interventions: Device: Integra® Dermal Regeneration Template;   Other: Conventional Wound Therapy
29 Completed
Has Results
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
Condition: Venous Leg Ulcer
Interventions: Device: Dermagraft(R);   Device: Profore
30 Active, not recruiting AngelMed for Early Recognition and Treatment of STEMI
Conditions: Acute Myocardial Infarction (AMI);   Coronary Occlusion;   Acute Coronary Syndrome
Intervention: Device: Guardian System
31 Terminated Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
Condition: Melanoma
Interventions: Drug: Elesclomol (STA-4783);   Drug: Paclitaxel
32 Active, not recruiting
Has Results
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Acetylsalicylic acid
33 Completed
Has Results
Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition: Venous Thrombosis
Interventions: Drug: Enoxaparin;   Drug: warfarin;   Drug: Placebo for apixaban;   Drug: Placebo for enoxaparin;   Drug: Placebo for warfarin;   Drug: apixaban
34 Completed
Has Results
Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition: Venous Thrombosis
Interventions: Drug: Apixaban;   Drug: Placebo
35 Terminated
Has Results
Bronchitis and Emphysema Advice and Training to Reduce Hospitalization
Conditions: COPD;   Emphysema
Intervention: Behavioral: COPD Self-management Education
36 Completed Does Gabapentin and Lamotriginel Have Significantly Fewer Side-Effects While Providing Equal or Better Seizure Control Than the Current Drug Choice, Carbamazepine, for the Treatment of Seizures in the Elderly.
Condition: Seizures
Interventions: Drug: Carbamazepine;   Drug: Gabapentin;   Drug: Lamotrigine
37 Recruiting Prevention of Serious Adverse Events Following Angiography
Conditions: Acute Renal Failure;   Kidney Disease;   Coronary Artery Disease
Interventions: Drug: IV isotonic saline;   Drug: IV isotonic bicarbonate;   Drug: N-acetylcysteine;   Drug: Placebo
38 Active, not recruiting Extended Steroid in CAP(e)
Condition: Community Acquired Respiratory Disease Syndrome
Intervention: Drug: Methylprednisolone
39 Completed
Has Results
Web-Enhanced Guideline Implementation for Post MI CBOC Patients
Conditions: Myocardial Infarction;   Comorbidity
Intervention: Behavioral: VA MI Plus Interactive
40 Completed Homocysteine Study (HOST)
Conditions: End Stage Renal Disease;   Renal Failure
Interventions: Drug: PAL-40 Active;   Drug: PAL-40 Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.